WCLC 2024 – Pascale Tomasini
Pascale Tomasini discusses the most promising strategies currently being investigated to overcome resistance to PD-(L)1 inhibitors in advanced non-small cell lung cancer, highlights the results of the PIONeeR trial while addressing the ongoing challenges in developing and implementing precision immuno-oncology treatments for PD-(L)1-resistant NSCLC patients.
